Long-acting octreotide for advanced liver cancer

A well-designed negative trial - Commentary

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)43-44
Number of pages2
JournalEvidence-Based Gastroenterology
Volume8
Issue number2
DOIs
StatePublished - May 2007
Externally publishedYes

Fingerprint

Octreotide
Liver Neoplasms

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{42869fb000de430d89b90c386a476773,
title = "Long-acting octreotide for advanced liver cancer: A well-designed negative trial - Commentary",
author = "Schwartz, {Jonathan M.}",
year = "2007",
month = "5",
doi = "10.1097/EBG.0b013e31805d27f9",
language = "English (US)",
volume = "8",
pages = "43--44",
journal = "Evidence-Based Gastroenterology",
issn = "1527-8557",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Long-acting octreotide for advanced liver cancer

T2 - A well-designed negative trial - Commentary

AU - Schwartz, Jonathan M.

PY - 2007/5

Y1 - 2007/5

UR - http://www.scopus.com/inward/record.url?scp=34247890050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247890050&partnerID=8YFLogxK

U2 - 10.1097/EBG.0b013e31805d27f9

DO - 10.1097/EBG.0b013e31805d27f9

M3 - Article

VL - 8

SP - 43

EP - 44

JO - Evidence-Based Gastroenterology

JF - Evidence-Based Gastroenterology

SN - 1527-8557

IS - 2

ER -